U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday.
Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday’s session after the FDA approved PALSONIFY.
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday.
Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday’s session after the FDA approved PALSONIFY.
Copyright © Louis Velazquez. All Rights Reserved.